Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Inhibitors of β-hydroxylase for treatment of cancer

Inhibitors of β-hydroxylase for treatment of cancer

US Patent 10710995 · Granted Jul 14, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-CHI3L1 antibodies for the detection and/or treatment of nonalcoholic fatty 2024
Isotopically-stabilized tetronimide compounds2024
Methods of using monoclonal antibodies targeting epitopes of ASPH2022
Anti-CHI3L1 antibodies for the detection and/or treatment of nonalcoholic fattly2021
Isotopically-stabilized tetronimide compounds2021
Monoclonal antibodies targeting epitopes of ASPH2021
Aspartate-β-hydroxylase induces epitope-specific T cell responses in tumors2020
Inhibitors of beta-hydroxylase for treatment of cancer2020
Inhibitors of beta-hydroxylase for treatment of cancer2020
Treating hepatitis B virus infections by administering receptor associated prote2019
Inhibitors of β-hydroxylase for treatment of cancer2019
Inhibitors of β-hydroxylase for treatment of cancer2019